SeaDragon Limited on 20 December 2019 announced the resignation of Matt McNamara from the Board of Directors, with effect from the 20 December 2019. Matt originally joined the Board in October 2012 and has represented substantial shareholder BioScience Managers as a director for the last seven years providing critical insights from his experience in other healthcare and medical sciences businesses. Jeremy Curnock Cook, who until this resignation was an alternate Director to Matt McNamara, will continue to represent BioScience Managers. At SeaDragon's next meeting of shareholders, shareholders will be asked to formally elect Jeremy Curnock Cook as a Director.